There continue to be significant gender disparities with women being underrepresented in medical professional society leadership roles, despite more women entering medical school. This study aimed to elucidate the pattern of representation of women in medical society presidential positions in the United States and Europe over the past 50 years. It further examines gender-related trends in the field of cardiology and among medical trainees. Using publicly available data from major medical societies, we calculated the number of male and female presidents in major medical societies across most specialties in the United States and Europe over the past 50 years. We also examined cardiology societies specifically. These numbers and percentages were observed alongside those of medical students, internal medicine residents, cardiology fellows, and attending cardiologists. Women constituted 4% and 0% of medical professional society presidents from 1974 to 2023 in the United States and Europe, respectively; this increased to a respective 32% and 40% in the past decade. For cardiology societies, the United States trended from 7% to 22% female presidents in the past 50 years, and Europe trended from 0% to 10%. Doctor of medicine and doctor of osteopathic medicine students have shown steady increases in women to now greater than 50%. Medicine residents, cardiology fellows, and cardiology attendings all have smaller percentages of women, though the number is increasing with time. While women remain underrepresented in medical professional society leadership in the United States and Europe, there is a trend toward more representation of women, which mirrors growth in this realm among medical trainees.
20 January 2024 in Journal of the American Society of Echocardiography
Abbreviation use in clinical and academic cardiology is widespread, yet there are few guidelines regulating the creation and utilization of abbreviations. Inconsistent abbreviations can introduce ambiguity and pose challenges to practice and research. The authors aimed to analyze how abbreviations are created and utilized in general cardiology and cardiac imaging society guidelines in order to assess whether ambiguities and discrepancies exist between societies. Abbreviation data were collected from 7 national and international societies of general cardiology and cardiac imaging over a 6-year span (2018-2023). Data were linguistically coded for abbreviation type, unique occurrence, meaning or sense count, and frequency of discrepancy between societies. Among a total of 5,394 abbreviation tokens, there were 1,782 unique entries. Among the unique entries, 227 (12.7%) had 2 or more associated meanings (senses), and thus were potentially ambiguous. Cardiac societies differed from each other, and also internally, in their use of abbreviations, with the European Society of Cardiology representing the highest frequency of discrepant abbreviation usage (14.5%). More than 12.7% of abbreviations in cardiology society guidelines had 2 or more corresponding meanings, potentially increasing the risks of miscommunication and misrepresentation. We call on cardiology and cardiac imaging societies to define and publish best practices regarding abbreviation creation and utilization.
12 October 2023 in The American Journal of Cardiology
Systemic lupus erythematosus and type 2 diabetes mellitus are chronic inflammatory diseases that impact kidney function. Glucagon-like peptide-1 receptor agonist (GLP-1 RA), have shown benefits in several inflammatory diseases. However, their role in systemic lupus erythematosus, particularly in lupus nephritis, and disease flare are not well understood. We explored the hypothesized association between exposure to GLP-1 RA and renal and inflammatory outcomes in patients with systemic lupus erythematosus and type 2 diabetes mellitus. This retrospective cohort study utilized a global database of electronic health records from approximately 141 million patients. After propensity score matching, the study included 9,386 systemic lupus erythematosus patients with type 2 diabetes mellitus, stratified by GLP-1 RA exposure. Among 9,386 systemic lupus erythematosus patients with type 2 diabetes mellitus, the average age in the GLP-1 RA-exposed group was 61.6 years. The relative risk of lupus nephritis was comparable (RR 0.57, 95% CI: 0.26-1.25, P = 0.15) at one-month follow-up; however, GLP-1 RA exposure was associated with a lower risk of lupus nephritis at one year (RR 0.59, 95% CI: 0.40-0.86, P < 0.01) compared to the control group. Secondary outcomes, including systemic lupus erythematosus flare, all-cause mortality, acute myocardial infarction, and hospitalization rate were observed less frequently in the GLP-1 RA group at one-year follow-up. The ischemic stroke risk was similar between the two groups at one month, however, GLP-1 RA exposure was associated with a lower risk of ischemic stroke at one year CONCLUSION: GLP-1 RA exposure in systemic lupus erythematosus patients with type 2 diabetes mellitus is associated with reduced risks of lupus nephritis, and systemic lupus erythematosus flares.